Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Fatemeh Talebian"'
Autor:
Mandana Mohyeddin Bonab, Fatemeh Talebian, Aida Borzabadi, Vahideh Nasr, Azam Abedi Kooshlshahi, Fahime Anisie, Ronaz Haghshenas, Bita Shalbafan, Ehsan Janzamin, Saeed Shahbeigi
Publikováno v:
Translational Medicine Communications, Vol 6, Iss 1, Pp 1-11 (2021)
Abstract Background Mesenchymal Stem Cells (MSCs) are multipotent cells with low immuonogenecity, and dynamic tissue repair potential, which explains the overwhelming attention they have attracted in regenerative therapy. One notable challenge in MSC
Externí odkaz:
https://doaj.org/article/c5d9bcd96439458fba7ed2199f6eb0c8
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
CD200-CD200R pathway regulates immune responses and has been implicated in the pathogenesis of a number of cancer types. CD200 blockade is considered a strategy for immunotherapy of CD200-positive cancers such as melanoma. Thus, it is critical to und
Externí odkaz:
https://doaj.org/article/ee097dcb6e834ebe89aedefa5c48ad9a
Publikováno v:
Urology Journal, Vol 4, Iss 1, Pp 1-9 (2007)
Introduction: Microchimerism has become a familiar term in the past few years. Many groups all over the globe, specializing in a diverse array of basic and medical sciences, have turned their attention to microchimerism, its possible role in disease
Externí odkaz:
https://doaj.org/article/ab5ba9f7380c401a948852039f483718
Autor:
Fatemeh Talebian, Jin-Qing Liu, Zhenzhen Liu, Mazin Khattabi, Yukai He, Ramesh Ganju, Xue-Feng Bai
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e31442 (2012)
CD200 is a cell surface glycoprotein that functions through engaging CD200 receptor on cells of the myeloid lineage and inhibits their functions. Expression of CD200 has been implicated in a variety of human cancer cells including melanoma cells and
Externí odkaz:
https://doaj.org/article/b1d721dd10544346844db392b6910fb1
Autor:
Jin-Qing, Liu, Chengxiang, Zhang, Xinfu, Zhang, Jingyue, Yan, Chunxi, Zeng, Fatemeh, Talebian, Kimberly, Lynch, Weiyu, Zhao, Xucheng, Hou, Shi, Du, Diana D, Kang, Binbin, Deng, David W, McComb, Xue-Feng, Bai, Yizhou, Dong
Publikováno v:
J Control Release
Cytokines are important immunotherapeutics with approved drugs for the treatment of human cancers. However, systemic administration of cytokines often fails to achieve adequate concentrations to immune cells in tumors due to dose-limiting toxicity. T
Autor:
Aiyan Hu, Jianmin Zhu, Chunxi Zeng, Cho-Hao Lin, Jianyu Yu, Jin-Qing Liu, Kimberly Lynch, Fatemeh Talebian, Xueliang Pan, Jingyue Yan, Yizhou Dong, Zihai Li, Xue-Feng Bai
Publikováno v:
J Immunol
IL-27 is a pleiotropic cytokine that exhibits stimulatory/regulatory functions on multiple lineages of immune cells including T lymphocytes. In this study, we demonstrate that IL-27 directly induces CCL5 production by T lymphocytes, particularly CD8+
Autor:
Cho-Hao Lin, Fatemeh Talebian, Li Yang, Jianmin Zhu, Jin-Qing Liu, Bolin Zhao, Sujit Basu, Xueliang Pan, Xi Chen, Pearlly Yan, William E. Carson, Gang Xin, Haitao Wen, Ruoning Wang, Zihai Li, Qin Ma, Xue-Feng Bai
Publikováno v:
iScience. 26:106904
Publikováno v:
American journal of translational research. 14(4)
CD24 is a glycosyl-phosphatidylinositol (GPI) anchored cell surface glycoprotein with a variety of immunomodulatory functions such as inhibition of thymic generation of autoreactive T cells, regulation of antigen presenting cell functions, and mediat
Autor:
Hamid Salehinia, Fatemeh Talebian, Leila Jouybari, Abolfazl Hosseinnattaj, Tahereh Yaghoubi, Mohammad Ali Heydari Gorji, Fereshteh Araghian Mojarad
Publikováno v:
Tabari Biomedical Student Research Journal.
Introduction: There is a lack of studies on the knowledge and attitudes of health care workers towards COVID-19. The aim of this study was to compare the knowledge and attitudes of nurses in emergency departments and special wards of medical training
Autor:
Bita Shalbafan, Fahime Anisie, Mandana Mohyeddin Bonab, Azam Abedi Kooshlshahi, Fatemeh Talebian, Aida Borzabadi, Vahideh Nasr, Saeed Shahbeigi, Ehsan Janzamin, Ronaz Haghshenas
Publikováno v:
Translational Medicine Communications, Vol 6, Iss 1, Pp 1-11 (2021)
Background Mesenchymal Stem Cells (MSCs) are multipotent cells with low immuonogenecity, and dynamic tissue repair potential, which explains the overwhelming attention they have attracted in regenerative therapy. One notable challenge in MSCs therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb820c96d242d2555f45af02a54641e4
https://doi.org/10.21203/rs.3.rs-379388/v1
https://doi.org/10.21203/rs.3.rs-379388/v1